Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial

The Lancet Gastroenterology & Hepatology

Fecha de publicación: 16 august 2018

DOI: https://doi.org/10.1016/S2468-1253(18)30234-6

Autores: Robert J S Coelen, MD, Eva Roos, MD, Jimme K Wiggers, MD, Prof Marc G, Besselink, MD, Carlijn I Buis, MD, Prof Olivier R C Busch, MD, et al

Background: In patients with resectable perihilar cholangiocarcinoma, biliary drainage is recommended to treat obstructive jaundice and optimise the clinical condition before liver resection. Little evidence exists on the preferred initial method of biliary drainage. We therefore investigated the incidence of severe drainage-related complications of endoscopic biliary drainage or percutaneous transhepatic biliary drainage in patients with potentially resectable perihilar cholangiocarcinoma.

Seguir leyendo